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Should be Supervised, Targeted, and
Prescribed With Referrals From
Oncologists and General Physicians
TO THE EDITOR: We agree with Hardcastle and Cohen1 that
physical activity is important for patients and survivors of cancer,
and that the oncology specialist is ideally suited to promote this
message. Indeed, a key strategy in cancer management is the in-
creased awareness by medical and health professionals who sup-
port patients with cancer and survivors that physical activity and
exercise is a critical component of patient care and a necessary
intervention to improve health outcomes; however, the recom-
mendations by Hardcastle and Cohen1 for implementation are an
oversimpliﬁcation that may adversely impact the integration of
exercise medicine into best practice management of cancer.
Preclinical studies,2 observational studies,3 and randomized
controlled trials4 demonstrate that the beneﬁts of targeted exercise
extend beyond the various components of physical ﬁtness to the
maintenance or enhancement of musculoskeletal health, a reduction
in metabolic and cardiovascular risk, and to systemic and local al-
terations thatmay actually impact tumor biology.5 Furthermore, it has
been demonstrated that speciﬁc exercise programs result in improved
chemotherapy completion rates,6 whereas targeted exercise pre-
scription before cancer surgery results in improved patient outcomes.7
Unfortunately, oncologists have no training in exercise medicine
and cannot realistically prescribe physical activity or exercise, and, as
Hardcastle and Cohen1 point out, available time with the patient is
a barrier. Moreover, although there are guidelines from several na-
tional organizations8 that recommend the completion of 75 to 150
minutes per week of moderate-to-vigorous aerobic exercise and two
or more resistance training sessions per week, this is a generic rec-
ommendation that will be ineffective and unachievable for many
patients with cancer, especially if they are to undertake this at home as
suggested by Hardcastle and Cohen.1 A preferable model is one in
which the oncologist provides a strong message that exercise will
beneﬁt the patient’s quality of life and reduce treatment toxicities, then
refers the patient to an appropriate allied health professional, such as
a clinical exercise physiologist or exercisemedicine doctor. The patient
could then receive a tailored exercise medicine prescription that is
designed to ameliorate the critical morbidities that cause them
the greatest discomfort and risk of death. For example, if the patient
is experiencing cachexia as a result of the cancer and treatments,
then a recommendation of 150 minutes per week of walking will
actually exacerbate the muscle, fat, and bone loss by increasing the
energy deﬁcit. Carefully prescribed resistance exercise, combined with
nutritional support, would be indicated in this case. We are doing
a disservice to our patients—compromising their quality of life
and chances of survival—by not providing themwith optimal exercise
medicine as a part of cancer treatment.
We acknowledge the ﬁnancial, accessibility, scalability, and pa-
tient preference considerations raised by Hardcastle and Cohen,1 but
we do not believe that patients or the oncology professions should
settle for a low-ﬁdelity, suboptimal, generic physical activity recom-
mendation. Research from our team and others clearly demonstrates
that home-based interventions9 are far less effective than those that are
completed under supervision by appropriate specialists in an exercise
clinic setting.10 Most patients with cancer will be older and have
numerous comorbidities, which places them at risk when exercising
unsupervised, particularly alone at home. Furthermore, it is difﬁcult
to implement a quality exercise programwith limited equipment and,
in particular, the required intensity to elicit speciﬁc physiologic ad-
aptations to reduce treatment toxicities and potentially enhance
systemic and local antitumor effects in a home-based intervention.
It is unsurprising that patients will prefer a walking program,
but they would also prefer to take a placebo pill that has no adverse
effects and can be consumed at home rather than having to
complete a course of chemotherapy infusions; however, we all
acknowledge that it is nonsensical to recommend a treatment that
will have no therapeutic beneﬁt just because it is more convenient
and bearable. Therefore, it is nonsensical to recommend home-
based walking exercise to a patient with cancer whose medical
condition requires a speciﬁc exercise prescription.
We commend Hardcastle and Cohen1 for their strong rec-
ommendation of physical activity promotion and agree that the
implementationmust include a brief and powerful recommendation
from the treating oncologist. Whereas the generic physical activity
guidelines may be applicable, albeit suboptimal, for relatively healthy
survivors of cancer, we reject this as a recommendation for patients
who are preparing for treatment, such as surgery, during treatment,
such as hormone therapy or chemotherapy, or who suffer signiﬁcant
treatment toxicities and comorbidities. The principal aim of exercise
in the oncology setting should be the incorporation of targeted
exercise medicine into best practice patient care.
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